C alcific aortic valve disease (CAVD) is a growing health problem in Western countries. Currently, more than 2% of people over the age of 65 and 4% over the age of 85 experience this condition, and the prevalence of this pathology is rising because the population is aging. 1 Recent research has shown that CAVD results from a complex inflammatory process similar to that found in atherosclerosis. In fact both diseases share common risk factors, such as age, smoking, hypertension, and hypercholesterolemia, involving common molecular mechanisms. 2 The Notch pathway is a local cellular signaling system that regulates cell fate determination, differentiation, and tissue patterning, and dysregulated Notch activity has pathological consequences. 3 Notch genes encode a group of transmembrane receptors (Notch1 to Notch4 in mammals), with a large extracellular region and an intracellular domain involved in nuclear signaling. Interaction of Notch receptors with their cognate membrane-bound ligands (Delta-like and Jagged/Serrate) activates Notch receptors and results in nuclear translocation of Notch intracellular domain. 4 In the nucleus, the Notch intracellular domain associates with the RBPJK/CSL effector transcription factor and recruits coactivator molecules such as MAML1 to activate the expression of target genes. 5 Notch signaling is required for endocardial differentiation and cardiac valve formation in the mouse. 6 During early valve development, Notch1 activity is detected in the endocardium overlying the presumptive valve territory and persists in the valve endocardium throughout development, 7 suggesting that Notch is important for cardiac valve morphogenesis and remodeling. Inactivating mutations in the human NOTCH1 gene have been identified in patients with severe early CAVD, usually in the context of a bicuspid aortic valve, 8 suggesting that Notch1 haploinsufficiency causes a genetic predisposition to both bicuspid aortic valve and CAVD. 9 We hypothesized that mice with reduced Notch signaling activity might readily develop CAVD when subjected to a hypercholesterolemic diet. To test this, we carried out parallel studies on mice with targeted mutations for either RBPJk or Notch1. RBPJK is the main nuclear Notch effector, and mutation of RBPJk leads to more severe and systemic phenotypes than are caused by mutation of any single Notch receptor. 10 We fed RBPJk and Notch1 heterozygous mutant mice a hypercholesterolemic diet supplemented with vitamin D (HCVD diet). Only RBPJk and not Notch1 heterozygous mice showed worsened hemodynamic parameters under these conditions, suggesting that additional Notch receptor(s) that we find to be expressed in valve tissue, may play an essential redundant function in valve homeostasis. To gain a mechanistic insight into the role of Notch in CAVD, we cultured porcine valve interstitial cells in calcifying media and inhibited Notch signaling in various manners. Molecular analyses revealed that Notch inhibition caused a reduction in Hey1 expression and activated a proosteogenic gene program that led to valve cell calcification.
Methods

Mice
We used Notch1 11 and RBPJk 10 targeted mutant mice that had been bred into a CD1 background for at least 20 generations. All animals had trileaflet aortic valves except for 1 Notch1KO/ϩ mouse, which presented a bicuspid valve and was removed from the study. Eightto 10-week-old heterozygous mutant mice for Notch1 (nϭ14) and RBP (nϭ14) mice and their wild-type (WT) littermate counterparts (nϭ28) were assigned to 2 treatment groups (nϭ7 per group) for a 16-week period: (1) control chow (CC) diet, and (2) an HCVD diet. Food intake and body weight were monitored regularly.
Diets
See Supplemental Methods, available online at http://atvb.ahajournals.org.
Plasma Cholesterol Levels
See Supplemental Methods.
Echocardiography
Echocardiograms were recorded with a 14-MHz linear probe on a Vivid-7 ultrasound scanner (General Electric Healthcare) by a single experienced sonographer (Y.B.), fully blinded to the animal study group. Conscious sedation was achieved with low-dose intraperitoneal ketamine (80 mg/kg). The left ventricular (LV) end-systolic and end-diastolic diameters and septum and posterior wall thickness were measured using the two-dimensional guided M-mode. Ejection fraction (EF) and fractional shortening (FS) were computed from these measurements. 12 B-mode and color-Doppler guided continuous-wave Doppler was used to record the maximal transvalvular jet velocity. Specifically, to avoid Doppler misalignment, coaxial interrogation of the aortic flow was ensured by the operator, and all the measurements were obtained using an angle of interrogation less than 30°. To correct for flow dependence we computed an EF velocity ratio (EFVRϭEF (%)/maximal aortic velocity [m/s]) as an additional indicator of disease severity. 13 This index was preferred as a flow-corrected index of valve sclerosis because obtaining robust measurements of LV outflow tract size is very difficult in mice, as is accurately positioning the left ventricular outflow tract pulsed-wave Doppler sample volume.
Histology, In Situ Hybridization, and Immunohistochemistry
Porcine Aortic Valve Interstital Cell Culture and Short Hairpin RNA Lentiviral Transduction
Quantitative and Semiquantitative Polymerase Chain Reaction
Statistics
All data are presented as meansϮSD. A 1-way ANOVA (means model) was used to estimate a set of planned contrasts. The control of the false discovery rate, 14 ie, the expected proportion of falsepositives among all significant tests, was used to take into account the multiplicity of the tests. We used 2-way analysis of variance (ANOVA) to study the effect of diet and genotype. For comparisons between groups, the least significant difference (LSD) test was used for post hoc testing. Spearman correlation coefficients (R) were used to evaluate the relationship between continuous variables. All statistical analysis was performed using the statistical package SPSS version 17.0 (SPSS Inc, Chicago, IL) and the open source statistical scripting language R. Probability (P) levels below 0.05 were considered significant.
Results
Valvular and Ventricular Functions Are Impaired in RBPJk Mutants
The WT and RBPKO/ϩ animals had similar baseline readings of transvalvular maximum velocity and EFVR (PϾ0.05). After 4 months on HCVD diet, RBPKO/ϩ mice had higher maximum velocity and lower EFVR values than WT animals (Pϭ0.05 and 0.01, respectively). Remarkably, the aortic valve maximum velocity was significantly higher in RBPKO/ϩ mice fed the HCVD diet than WT or RBPKO/ϩ mice on the CC diet (increased 20%, from 1 to 1.20Ϯ0.09 m/s; PϽ0.05; Figure 1A and 1E). Moreover, EFVR was lower in RBPKO/ϩ mice fed the HCVD diet (decreased 45%, from 70 to 46Ϯ17) than in RBPKO/ϩ mice fed the CC diet or in WT mice fed the HCVD diet ( Figure 1D ). No significant dietary effect was found on echocardiography measurements in Notch1KO/ϩ animals (Supplemental Figure I) .
RBPKO/ϩ and WT animals had similar baseline FS and EF values (PϾ0.05). At 4 months, RBPKO/ϩ mice had significantly lower FS and EF values than WT (PϽ0.05, Figure 1B and 1C), suggesting an important genotype effect. Moreover, these values were significantly lower in RB-PKO/ϩ mice fed the HCVD diet (PϽ0.05). RBPKO/ϩ mice, but not their WT littermates, showed a significant correlation between transvalvular velocity and levels of total cholesterol (Rϭ0.77; PϽ0.01) and low-density lipoprotein cholesterol (Rϭ0.82; PϽ0.001) (Supplemental Figure IIA and IIB) , suggesting that the adverse hemodynamic parameters were associated with hypercholesterolemia in RBPKO/ϩ mice. Thus, RBPKO/ϩ mice fed the HCVD diet developed a functional impairment in both aortic valve and left ventricle.
RBPJk Heterozygous Mice Display Aortic Valve Fibrosis and Inflammation
Histological analysis at 16 weeks indicated that leaflet thickness, as determined by quantifying valvar cuspal area, was unaffected by the CC diet in WT or RBPKO/ϩ mice ( Figure  2A , 2C, and 2M). Cusps were thicker (PϽ0.05) in WT, Notch1 KO/ϩ, and RBPKO/ϩ animals fed the HCVD diet ( Figure 2D , 2E, 2F, and 2M). Leaflets were also thicker in Notch1KO/ϩ mice fed the CC diet ( Figure 2B and 2M) compared with WT littermates (PϽ0.05; Figure 2A and 2M). However, the diet did not have any significant effect on leaflet thickness of Notch1KO/ϩ mice ( Figure 2B , 2E, and 2M). The most significant increase was found in RBPKO/ϩ mice fed the HCVD diet (PϽ0.01; Figure 2F and 2M). Collagen distribution in the leaflets of WT, Notch1KO/ϩ, or RBPKO/ϩ mice fed the CC diet appeared to be restricted to a thin fibrosa layer ( Figure 2A , 2B, 2C, and 2M; green-blue staining). In contrast, collagen in animals fed the HCVD diet extended all over the valve area most extensively in RBPKO/ϩ mice valves ( Figure 2D , 2E, 2F, and 2M).
To detect macrophage infiltration, we stained aortic valve sections with anti-Mac3 antibody. 15 Mac3 staining was absent in the valve leaflets of mice fed the CC diet ( Figure 2G , 2H, 2I, and 2N), but weak staining was seen at the base of the leaflets in WT mice fed the HCVD diet ( Figure 2J and 2N ). Macrophage infiltration was detected in the leaflets of Notch1KO/ϩ and RBPKO/ϩ mice fed the HCVD diet, mostly at the leaflet base fading toward the leaflet tips ( Figure   2K , 2L, and 2N). Thus, macrophage infiltration was increased in Notch1KO/ϩ valve leaflets and more so in the RBPKO/ϩ leaflets.
To corroborate that fibrosis was indeed taking place in the valves of hyperlipidemic mice, we examined transforming growth factor-␤1 (Tgf␤1) and the activated phosphorylated (p) form of its intracellular effector, Smad2. 16 Immunostaining of Tgf␤1 or p-Smad2 was negligible in WT or RBPKO/ϩ mice fed the CC diet (Supplemental Figure 
Notch Signaling Abrogation Activates a Proosteogenic Program in Hypercholesterolemic Animals
To determine whether the stenotic valve cells had converted into osteoblast-like cells, 17 we examined the expression of the osteogenic transcription factors p-Smad1/5/8, the intracellular effector of bone morphogenic protein 2 (Bmp2) in its activated form, 18 and the master regulator Runx2. 19 Immunofluorescence for p-Smad1/5/8 or Runx2 was negligible in WT and RBPKO/ϩ mice fed the CC diet ( Figure 3A , 3C, 3G, 3I, 3M, and 3N). p-Smad1/5/8 staining was increased in WT mice fed the HCVD diet ( Figure 3D and 3M), whereas Runx2 was found on the leaflet base extending toward the leaflet tips ( Figure 3J and 3N ). These expression patterns were similar to those observed in valves of HCVD-fed Notch1KO/ϩ mice ( Figure 3E , 3K, 3M, and 3N), which also showed relatively high levels of p-Smad1/5/8 and Runx2 expression when fed the CC diet ( Figure 3B, 3H, 3M, and 3N) . Interestingly, the RBPKO/ϩ mice fed the HCVD diet exhibited intense p-Smad1/5/8 and Runx2 immunostainings over the whole leaflet area ( Figure 3F , 3L, 3M, and 3N).
To confirm this phenotype, we examined Osterix and Osteopontin, which are regulated by Runx2 20 and Bmp2, 21 respectively. Weak background staining was found in aortic valve leaflets of WT and RBPKO/ϩ mice fed the CC diet (Supplemental Figure IVA fed the HCVD diet and were more conspicuously present in RBPKO/ϩ mice.
Osteogenesis Is Associated With Valve Leaflet Calcification in Notch Mutants
To examine the presence of calcification in the valve cusps, we used Von Kossa staining. The presence of melanocytes in AV and aortic valves may confound the interpretation of Von Kossa staining and has been considered an issue previously in C57BL/6 mice; however, this is not the case in CD1 mice, where melanocytes do not accumulate, and this is an advantage of using this outbred strain. No calcification was observed in the aortic valve leaflets of WT mice fed the CC diet ( Figure 4A and 4G) or in RBPKO/ϩ mice fed the CC diet ( Figure 4C and 4G ). Weak staining (Ϸ0.5% of leaflet area) was detected in WT mice fed the HCVD diet ( Figure 4D and 4G) and Notch1KO/ϩ mice fed the CC diet ( Figure 4B and 4G). Moderate staining (Ϸ1% of leaflet area) was found in Notch1KO/ϩ mice fed the HCVD diet ( Figure 4E and 4G) .
The most extensive staining was found in RBPKO/ϩ mice fed the HCVD diet, covering Ϸ2.5% of the valve area ( Figure  4F ) (PϽ0.05), These data indicated that calcification was more extensive in RBPKO/ϩ mice fed the HCVD diet.
Widespread Notch Receptor Expression in Murine Aortic Valve Leaflets
As the phenotype of RBPKO/ϩ was more severe that than of Notch1KO/ϩ mice, we examined whether in addition to Notch1, other Notch receptors were also expressed in valve tissue. Notch1 mRNA was detected in the endothelium and interstitial cells of the aortic valve leaflets of WT CD1 mice (Supplemental Figure VA 
NOTCH Signaling Inhibition Downregulates HEY1 mRNA and Enhances Calcification in Porcine Valve Interstitial Cell Culture
To gain mechanistic insight into CAVD in RBPKO/ϩ mice, we used porcine aortic valve interstitial cells (PAVIC) cultured in calcifying medium and inhibited Notch signaling using the
␥-secretase inhibitor N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-Sphenylglycine t-butyl Ester (DAPT)
. After 3 weeks in calcifying medium, alizarin red staining revealed sparse calcification foci in control cells. In contrast, the DAPT-treated PAVIC exhibited a 2-fold increase in number of large calcification nodules ( Figure  5A and 5B; PϽ0.05). Alizarin red staining revealed few calcification foci in control cultures and increased calcification in DAPT-treated PAVIC ( Figure 5A ). Reverse transcription-polymerase chain reaction analysis of Notch target genes showed that Hey1 expression was reduced, whereas Hes1 and Hey2 remained unchanged in DAPT-treated cells compared with control cultures ( Figure 5C ). Concomitantly, the osteogenic markers BMP2, Runx2, alkaline phosphatase (ALP), and osteocalcin (BGLAP/OTC) were also upregulated ( Figure 5C ). These data suggest that Notch represses calcification in PAVIC by maintaining/activating Hey1 expression.
To further support these data, we transduced PAVIC cultures with MAML1 and RBPJk short hairpin RNAs (shRNAs). After 2 weeks of culture in calcifying medium, the cultures transduced with control lentiviral vector showed very sparse calcification areas ( Figure 5D and 5E), whereas PAVIC transduced with shRNA against MAML1 or RBPJk showed a marked increase in area of calcification ( Figure 5D and 5E). Reverse transcription-polymerase chain reaction analysis of these cultures indicated a clear reduction in MAML1 and RBPJk transcription ( Figure 5F ). These data demonstrated that Notch signaling attenuation caused calcification in PAVIC. 
Discussion
We have established a genetic model of CAVD by feeding RBPJk heterozygous mice a hypercholesterolemic diet. Under similar experimental conditions, Notch1 heterozygous mice developed adverse histopathology but no significant hemodynamic disturbance, consistent with the expression of Notch2, Notch3, and Notch4 in the valves, any of which might be important for aortic valve homeostasis. These results imply that mutations in other human NOTCH receptors might be found in CAVD observed in sporadic and familial cases where NOTCH1 is not mutated.
RBPJk Heterozygous Mutant Mice Develop Aortic Valve Disease
We show that the RBPKO/ϩ mice fed an HCVD diet for 4 months develop CAVD. Compared with WT animals, indexes of valvular dysfunction increased during follow-up in RBPKO/ϩ mice, highlighting an adverse interaction between diet and genotype in these mice. Importantly, the transvalvular maximum velocity in RBPKO/ϩ mice was higher than in controls, despite a parallel reduction of LV systolic function indexes. These findings were confirmed by the EFVR, which is a flow-corrected index. Moreover, RBPKO/ϩ mice had LV dysfunction highlighting the additive effect of predisposing genotype and dietary (environmental) factors in cardiac valve disease. Notch signaling is essential for ventricular chamber development, 22 and these observations are consistent with a critical role for Notch in maintaining ventricular homeostasis in adulthood. 23 
Notch Mutant Valve Tissue Displays Hallmarks of CAVD
Epidemiological data and evidence from hyperlipidemic animal models 2, 24 have indicated that CAVD is an atherosclerotic-like process involving endothelial inflammation, fibrosis, and calcification. In our murine models, we used a hyperlipidemic, vitamin D-supplemented diet to drive valvular inflammation, fibrosis, and calcification processes over a 16-week period. 25 Demonstration of the expression of Notch pathway elements in macrophages within atherosclerotic plaques has led to the suggestion that Notch signaling mediates inflammatory responses and promotes inflammation. Thus, Delta4 has been shown to trigger Notch proteolysis and macrophage activation in culture, whereas Notch3 knockdown during macrophage differentiation decreased the transcription of proinflammatory genes implicated in atherosclerosis. 26 Unexpectedly, we found more conspicuous evidence for inflammation in both RBPKO/ϩ and Notch1KO/ϩ mouse models (detected by Mac-3 staining), suggesting that reduced Notch dosage promotes the inflammatory response. This proinflammatory effect may be partially explained by increased sensitivity of endothelial cells to lipid-induced damage in Notch mutants. For example, it has been shown that impaired Notch4 activity in graft endothelium of transplant atherosclerosis results in vascular cell adhesion molecule-1 expression and endothelial cell apoptosis. 27 The increased inflammation observed in our mutants might represent the outcome of diminished Notch function both in macrophages and endothelium, with the effect that the endothelial phenotype is dominant.
The extracellular matrix layering the aortic valve cusp in mouse is organized into collagen in the fibrosa (or arterial aspect of the cusp), elastic fibers in the ventricularis (ventricular aspect), and proteoglycans in the spongiosa. 28 Compared with that of human, it contains relatively less collagen in the fibrosa and elastin in the ventricularis, whereas valve interstitial cells density is qualitatively increased throughout. Mice undergo age-associated degeneration that primarily affects the annulus, similar to degeneration in humans, but involves proteoglycan accumulation instead of the collagen seen in humans. 29 We suspect that the more pronounced valve cusp thickening in the HCVD diet-fed RBPKO/ϩ mice and, to a lesser degree, Notch1 KO/ϩ mice was associated with increased fibrosis, as it correlated well with the observation of enhanced TGF␤1 signaling (through p-Smad2) in valve leaflets. TGF␤1 is a potent stimulator of collagen-producing cardiac fibroblasts and when chronically overexpressed causes tissue fibrosis and organ dysfunction. 30 Excessive mesenchymalization and extracellular matrix deposition have been shown to negatively affect valve mechanics by causing stiffening, loss of flexibility, and restricted leaflet motion. In One-way ANOVA and LSD post hoc analysis were used to compare differences between groups. Bars with different letters indicate significant differences (PϽ0.05) vs all other groups (LSD post hoc analysis). Scale barϭ0.1 mm.
addition, abnormal extracellular matrix mineralization can be the trigger for valve calcification and stenosis. 31 Finally, calcification constitutes the end stage process and chief indicator of disease in patients. 32 In the RBPKO/ϩ (and to a lesser extent, Notch1KO/ϩ) valve leaflets, increased Bmp2 signaling (via p-Smad1/5/8) and upregulation of Runx2, Osterix, and Osteopontin were consistent with the activation of an osteogenic-like gene program seen in CAVD patient valves 33 and animal models. 24 The calcification detected in RBPKO/ϩ mice was mild compared with humans with CAVD. This may indicate that given their CD1 atherosclerosis-resistant background, these mice are naturally resistant to calcification or that the process of leaflet mineralization requires longer follow-up. Nevertheless, calcification in RBPKO/ϩ mice was associated with significant hemodynamic dysfunction, suggesting that other factors, such as fibrosis and leaflet thickening (ie, sclerosis), could contribute to the worsened hemodynamics seen in this model.
Notch Signaling Inhibits Valve Calcification
It has been suggested that Notch1 maintains myofibroblast cell fate and blocks osteogenesis in valve leaflets by downregulating the transcriptional and signaling activities of Runx2/Cbfa1 8 and Bmp2. 34 In agreement with this notion, Runx2 and Bmp2 expression or signaling activity was found to be consistently upregulated in vivo in aortic valves of HCVD-fed RBPKO/ϩ mice and in vitro, in PAVIC cultures treated with the Notch inhibitor DAPT. Moreover, our study points to Hey1 as a key Notch target gene whose downregulation is associated with osteogenic gene expression and calcification in vivo and in vitro. Hey1 has been shown to be an important negative regulator of cell differentiation/maturation programs by transcriptional repression of tissuespecific target genes (reviewed in 35 ). Downregulation of Hey1 mRNA by small interfering RNA in osteogenic lineagederived mouse calvarial MC3T3 cells induced matrix mineralization in conjunction with osteogenic gene expression, suggesting that Hey1 acts as a negative regulator of osteoblast maturation. 36 This was demonstrated to occur via interaction with Runx2, with the effect that Hey1 partially abrogated Runx2 transcriptional activity. 8, 36 Notch1 signaling has also been shown to activate Hey1 transcription directly, by virtue of RBPJK consensus binding sites present within the 5Ј-end promoter region and the first coding exon of the Hey1 gene. 37 Our findings suggest a model (shown in Figure 6 ) in which Notch inhibits the osteoblast and maintains the myofibroblast cell fate in the aortic valve by activating Hey1 directly through RBPJK. Hey1 in turn abrogates the transcriptional activity of Runx2 or other critical regulators of the osteogenic program that we have seen to be upregulated in vivo in the Notch1KO/ϩ and RBPKO/ϩ valve leaflets and in vitro in PAVIC cultures treated with DAPT ( Figure 5E ). Interestingly, Hey1 has been identified as a direct target for BMPmediated osteogenic differentiation 36 and suggests that a crosstalk between BMP and Notch signaling modulates the interaction between Hey1 and other nuclear factors, such as Runx2.
Is There a Notch Receptor Redundancy in Aortic Valve Homeostasis?
Our study lends support to the idea that Notch1 haploinsufficiency causes a less severe aortic valve phenotype in mice than in humans. Indeed, male Notch1KO/ϩ mice fed a Western diet for 10 months also exhibited mild (albeit increased) calcification compared with WT littermates in the absence of any functional impairment. 34 Thus, the finding of sclerosis (ie, valve dysfunction) in RBPKO/ϩ mice broadens these studies by implying that Notch receptors play nonredundant functions in aortic valve homeostasis. This assumption is also supported by our finding widespread Notch receptor expression in aortic valve leaflets. Notch2 mRNA was detected in valve interstitial cell tissue, and Notch4 mRNA showed an expression pattern similar to that of Notch1 in the endothelial cell layer, but at lower levels. We did not detect Notch3 in valve leaflets, but this receptor may play a role in the setting of hypertension associated with aortic valve disease. 38 
Limitations of the Study
One factor influencing our study has to do with the genetic background of our mice. Our Notch mutant mice (Notch1KO/ϩ and RBPKO/ϩ) have been bred into a CD1 background that is relatively resistant to atherosclerosis (unpublished data). We did not consider this an issue because we undertook a comparative study examining RBPKO/ϩ versus Notch1KO/ϩ and CD1 WT control mice. We used an atherogenic diet containing cholesterol and cholate, often used to study the pathology and genetics of atherosclerosis in inbred mouse strains 39 and supplemented with vitamin D; this diet has been shown to cause CAVD in other settings. 25 However at 4 months, adverse effects affecting all the mice precluded longer follow-up. Most of the hemodynamic changes in the RBPKO/ϩ mice were quite modest at this stage, despite clear evidence of valvular inflammation, thickening, and osteogenic transformation, but they were nevertheless significant compared with Notch1KO/ϩ or WT mice. Given that CAVD is a stage-dependent process, we suspect that a longer follow-up would have allowed the development of overt stenosis.
Conclusions
The murine model described herein represents a first approximation of CAVD caused by reduced Notch dosage. Most likely, Notch operates at multiple levels of disease progression, and it will be necessary in future studies to determine what impact tissue-specific effects have on disease overall. Moreover, breeding the mutants into an atherosclerosis-prone background (ie, ApoEKO) will permit longer follow-up studies. From a clinical standpoint, our data suggest the existence of a population of patients at risk and likely to harbor mutations of NOTCH signaling elements other than Notch1. Systematic examination of each Notch component individually should help clarify the full contribution of the Notch pathway to CAVD. 
